Loughborough, United Kingdom

Michael Stocks

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 34(Granted Patents)


Location History:

  • Nottingham, GB (2000)
  • Long Eaton, GB (1999 - 2001)
  • Loughborough, GB (2006 - 2010)

Company Filing History:


Years Active: 1999-2010

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Michael Stocks: Innovator in Pharmaceutical Compounds

Introduction

Michael Stocks is a renowned inventor based in Loughborough, GB, with a notable portfolio of 8 patents to his name. His work primarily focuses on innovative compounds with therapeutic applications, particularly in the field of pharmaceuticals.

Latest Patents

Among his latest innovations, Michael Stocks has developed various significant compounds. One of his notable patents involves Benzothiazolone derivatives, which provide a new class of pharmaceutical compounds for therapeutic use. The invention includes processes for their preparation, pharmaceutical compositions containing them, and their application in therapy. Another significant patent concerns N-pyrazinyl-phenylsulphonamides, which are designed for the treatment of chemokine-mediated diseases, particularly emphasizing inflammatory conditions such as asthma.

Career Highlights

Michael has established himself as a valuable contributor within the pharmaceutical industry, having worked with prominent companies such as AstraZeneca AB and AstraZeneca UK Limited. His experience at these organizations has allowed him to translate innovative ideas into practical applications.

Collaborations

Throughout his career, Michael has collaborated with accomplished professionals, including David R. Cheshire and David Cladingboel. These partnerships have enhanced his research and development efforts, fostering a collaborative spirit in the pursuit of medical advancements.

Conclusion

With a focus on therapeutic innovation, Michael Stocks continues to push the boundaries of science and medicine through his extensive patent portfolio. His work not only demonstrates his commitment to improving health outcomes but also positions him as a key player in the ongoing advancement of pharmaceutical technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…